Countries North America
Thermo Fisher Expands North American Oral Drug Development Capabilities with $22M Investment in Cincinnati and Bend Sites
Additions to sites in Cincinnati, Ohio, and Bend, Ore. broaden early development capabilities to help accelerate pre-clinical oral drug product innovation ...
September 27, 2024 | News
Bloomage Completes Cutting-Edge Pilot-Scale Testing Platform to Accelerate Biomanufacturing Innovation
Bloomage, a global leader specializing in hyaluronic acid and other bioactive substance innovations, has announced the completion of its new pilot-scale te...
September 26, 2024 | News
Telix Pharmaceuticals to Acquire RLS Radiopharmacies, Expanding U.S. Manufacturing Footprint and Radiometal Production Network
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS Radiopharmacies), the only Joint Commission-accredited radiopharmacy n...
September 23, 2024 | News
GE HealthCare Introduces Venue Sprint™: A Portable, Advanced Ultrasound Solution for Point-of-Care Excellence
Unveiling Venue Sprint™, the latest Venue family solution offering maximum portability and advanced capabilities for high-quality scanning an...
September 20, 2024 | News
Hyundai Bioscience Partners with UC San Diego for Pioneering Long-COVID Clinical Trial of Antiviral Xafty®
Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...
September 18, 2024 | News
Coya Therapeutics Demonstrates Promising CNS Anti-Inflammatory Effects of COYA 302 in Parkinson’s Disease Model
A key aspect of Parkinson’s disease (PD) pathophysiology is decreased systemic regulatory T cell (Treg) function with associated neuroinflammat...
September 17, 2024 | News
FDA Approves Eli Lilly's EBGLYSS™ for Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 and Over
Eli Lilly and Company (NYSE: LLY) announced the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 ...
September 16, 2024 | Analysis
Bambusa Therapeutics Secures $15M in Series Seed Funding to Advance Bispecific Antibody Pipeline
Bambusa Therapeutics Inc., a biotechnology company focused on developing bispecific antibodies for the treatment of immunological and inflammatory (I&I...
September 10, 2024 | News
NextPoint Therapeutics Introduces NPX372, a Novel T Cell Engager Targeting B7-H7 Axis in Solid Tumors
NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targetin...
September 09, 2024 | News
Arsenal Biosciences Closes $325 Million Series C Funding to Advance Next-Gen CAR T-Cell Therapies for Solid Tumors
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...
September 05, 2024 | News
Noetik Secures $40M in Oversubscribed Series A to Advance AI-Driven Cancer Therapeutics
Noetik, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therape...
September 02, 2024 | News
Biocon Biologics Secures Market Access for Bmab 1200 in Europe, UK, Canada, and Japan Through Janssen Settlement
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has signed a settleme...
August 29, 2024 | News
Cygnus Technologies and TriLink BioTechnologies Collaborate to Launch Cutting-Edge AccuRes™ Host Cell DNA Quantification Kits
Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink®), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to ...
August 29, 2024 | News
Propanc Biopharma Secures Canadian Patent for PRP Proenzyme Composition, Strengthening Global IP Portfolio
-Propanc Biopharma, Inc. a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,&n...
August 16, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
